Endstage Renal Disease clinical trials

Explore recruiting endstage renal disease clinical trials.

Recruiting endstage renal disease studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Endstage Renal Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND PHARMACOKINETICS OF MIGALASTAT HCL IN SUBJECTS WITH FABRY DISEASE AND AMENABLE GLA VARIANTS AND SEVERE RENAL IMPAIRMENT OR END-STAGE RENAL DISEASE TREATED WITH HEMODIALYSIS

Spain, France, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

Endstage Renal Disease trials by city

Endstage Renal Disease in Toronto Endstage Renal Disease in Vancouver Endstage Renal Disease in Montreal Endstage Renal Disease in Calgary Endstage Renal Disease in Edmonton Endstage Renal Disease in Ottawa Endstage Renal Disease in Winnipeg Endstage Renal Disease in Quebec City Endstage Renal Disease in Hamilton Endstage Renal Disease in Kitchener Endstage Renal Disease in London Endstage Renal Disease in Halifax Endstage Renal Disease in New York Endstage Renal Disease in Los Angeles Endstage Renal Disease in Chicago Endstage Renal Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease